Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc. (0H8E.L) Stock Overview
Explore Accelerate Diagnostics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
138.7K
P/E Ratio
-0.01
EPS (TTM)
$-1.06
ROE
1.21%
0H8E.L Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Accelerate Diagnostics, Inc. (0H8E.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 0.58, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $1.53.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.01 and a market capitalization of 138.7K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.
Jack Phillips
107
3950 South Country Club Road, Tucson, AZ
2018